The $30 million facility was made possible, in part, through a $4 million contribution through the AdventHealth Palm Coast ...

The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...

Around 1,200 people with advanced breast cancer could benefit from a decision by NICE to give the go-ahead to a new treatment ...

Dr. Maxwell Lloyd shared the importance of improving patient access to innovative therapies like Orserdu at the 2024 San Antonio Breast Cancer Symposium.

Cite this: SABCS 2024: New Treatment Options in HR+/HER2- Breast Cancer - Medscape - Jan 10, 2025.

IntroductionThe global cancer therapeutics market is on an exponential growth trajectory, driven by advancements in treatment ...

Dawn Klemow, MD, assistant clinical professor, University of Texas Southwestern Medical Center, previews some of the most recent advances in breast cancer treatment.

Discover the 3 critical warning signs of breast cancer that every Black woman should know, plus insights on early detection ...

The Institute of Cancer Research, London, strongly welcomes the decision by NICE to recommend that the targeted drug olaparib can be used for locally advanced or metastatic breast cancer.

Instead, we're recruiting healthy soldiers from disease-free, well donors and equipping them with special targeting systems ...

Researchers sought to determine the effect of changes in screening guidelines on incidence of breast cancer by stage at diagnosis and surgical management.